|
||
| - -HOME - -ABOUT - -TECHNOLOGIES ...PIPELINE - -MANAGEMENT- -  ADVISORY BOARD- -INVESTORS - -CAREERS - -CONTACT |
||
| Advisory Board | |
Professor Jonathan Hadgraft Jonathan was educated at the University of Oxford where he obtained his M.A. and D.Phil. in Chemistry. Subsequently the Faculty of Medicine awarded him a D.Sc. In May 2004 he joined The School of Pharmacy, University of London where he is professor of Biophysical chemistry. He has held academic posts at the Universities of London, Strathclyde, Nottingham , Cardiff and Greenwich . During his career he has been involved in the supervision of over 60 Ph.D. students. He holds visiting professorships at the North West University , Potchefstroom , South Africa and Monash University , Melbourne , Australia .
Professor Karrar A Khan, Ph.D. Professor Khan has over 35 years experience of drug discovery, pharmaceutical development, registration and managing pharmaceutical scientists. His experience includes 20 years as Head of Pharmaceutical Development for Boots Pharmaceuticals and Knoll and two years as Director for OSI where he managed their pharmaceutical development, analytical operations and DMPK. Professor Khan has also held various product development and management positions with Abbott Laboratories, and Beecham Pharmaceuticals. In these roles, he developed medicines for several therapeutic areas including antibiotics, anti depressant, anti inflammatory, anti obesity, psychosis, cardiovascular, pain, cancer, parkinson disease, diabetes and skin. Professor Khan developed and contributed to the launch of two once a day controlled release dosage forms. His expertise range from development for phase 1 to phase 3- 4 and significant experience of bringing prescription and OTC products to market on a global level (and has contributed to the registration and launch of over 60 pharmaceutical products). He is a Qualified person under the EC quality assurance directive. Professor Khan has authored or co-authored more than 40 scientific publications and is an inventor of several development patents. He has been an invited speaker at many national and international conferences.
Professor Audra L. Stinchcomb, Ph.D.Professor Stinchcomb is Associate professor of Pharmaceutics at the University of Kentucky College of Pharmacy, Lexington , USA . Her expertise and research activities span the fields of novel pro-drugs and co-drugs development for transdermal delivery, intranasal delivery, and testing of novel materials for transdermal patches and associated bioanalytical methodology. She holds several issued patents in the field, and is founder and CSO of a specialty Pharma company. Her research work has brought in over $3,000,000 in funding from federal and industrial sources to date. She serves as a reviewer for over twenty pharmaceutical and drug delivery journals, and is on the editorial advisory board of Pharmaceutical Research and the Journal of Pharmaceutical Sciences. She has served as a member of the United States Pharmacopeia, an Institutional Review Board for clinical research, and as a scientific advisor for the EPA and NIOSH. She is currently a member of the American Association of Pharmaceutical Scientists, the Controlled Release Society, and the International Cannabinoid Research Society. |
|
HOME | ABOUT | TECHNOLOGIES | PIPELINE | MANAGEMENT Registered Name: Nemaura Pharma Limited |
||